1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMRFF – 2025 Early to Mid-Career Researchers Grant Opportunity is sponsored by National Health and Medical Research Council (NHMRC). Supports medical research and innovation projects led by early to mid-career researchers.
Get alerted about grants like this
Save a search for “National Health and Medical Research Council (NHMRC)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# MRFF – 2025 Early to Mid-Career Researchers Grant Opportunity (GO7553) | NHMRC * Health adviceOpen submenu * Research policyOpen submenu * Manage your fundingOpen submenu * NHMRC grant programOpen submenu * Medical Research Future Fund * International collaborative fundingOpen submenu * Targeted Calls for Research * Outcomes and data on researchOpen submenu * Working together to support research Close submenuManage your funding * NHMRC FundingOpen submenu * MRFF FundingOpen submenu Close submenuNHMRC Funding * Funding agreement and deed of agreement * Administering InstitutionsOpen submenu * Direct Research Cost Guidelines * Personnel and Salary Support PackagesOpen submenu Close submenuAdministering Institutions * Institutional Annual Compliance Report * Progress, final and additional reporting Close submenuPersonnel and Salary Support Packages * Previous Personnel Support Package rates * Previous Salary Support Package rates Close submenuMRFF Funding * MRFF Eligible OrganisationsOpen submenu * Reporting and milestonesOpen submenu * Direct Research Costs and Personnel and Salary Support Packages Close submenuMRFF Eligible Organisations * Institutional approvals and grant conditions Close submenuReporting and milestones * Scientific reporting and milestones Close submenuNHMRC grant program * NHMRC grant program schemes Close submenuInternational collaborative funding * International engagement strategy and activities * International collaborative health research funding * Other opportunities for international collaboration Close submenuOutcomes and data on research * Outcomes of funding rounds Close submenuHealth advice * Aboriginal and Torres Strait Islander health * Children’s health and development * Environmental healthOpen submenu * Public healthOpen submenu * Guidelines for Guidelines Close submenuEnvironmental health * Water quality and health Close submenuPublic health * Health effects of water fluoridation * Complementary medicines Close submenuResearch policy * Consumer and community involvementOpen submenu * Embryo research licensingOpen submenu * International engagement * Gender equityOpen submenu * Research prioritiesOpen submenu Close submenuConsumer and community involvement * Consumer and community engagement * Consumer and community representatives in peer review * Guidance for consumer and community involvement in health and medical research Close submenuEmbryo research licensing * Commonwealth and State Legislation * Information for applicants * Information for Licence Holders * Embryo Research Licensing Committee reports to parliament * Import and export of cell lines * Database of Licences issued * Training and Quality Assurance * National Statement on Ethical Conduct in Human Research * Ethical guidelines for research with Aboriginal and Torres Strait Islander Peoples * Ethical guidelines for Assisted Reproductive Technology * Ethical guidelines for cell, tissue and organ donation and transplantation * Guide for assessing research involving AI * Human research ethics committees * National Certification Scheme * The Human Research Ethics Applications (HREA) * Ethical issues and further resources Close submenuGender equity * NHMRC Gender Equity Strategy * Structural priority funding and gender equity * Administering Institutions – consideration of gender equity * Statement on Sex and Gender in Research * Sex, gender, variations of sex characteristics and sexual orientation in the grant program Close submenuResearch priorities * Community research priorities portal * NHMRC health priorities 2024–2027 * Regional, Rural and Remote Health Equity * Framework for Identifying and Prioritising Targeted Calls for Research * Targeted Calls for Research Prioritisation Criteria Rubric * Guide for Proposing Targeted Calls for Research * Leadership and governanceOpen submenu * Publications and resourcesOpen submenu * NHMRC AwardsOpen submenu * Accountability and reporting Close submenuLeadership and governance * Legislative basis to NHMRC * Senior executive and leadership team Close submenuPublications and resources * Annual reports and corporate plans Close submenuNHMRC Awards * Research Excellence Awards * Temporary Employment Register * How we select our people * Indigenous internship program [](https://www.
nhmrc. gov.au/ "Home") * Outcomes of funding rounds [](https://www. nhmrc.
gov.au/funding/find-funding/mrff-2025-early-mid-career-researchers-grant-opportunity-go7553#off-canvas "Menu") * Medical Research Future Fund * International collaborative funding * Targeted Calls for Research * Outcomes and data on research * Working together to support research Research funding statistics and data * Aboriginal and Torres Strait Islander health * Children’s health and development * Guidelines for Guidelines Guidelines for Guidelines * Consumer and community involvement * Embryo research licensing * International engagement Embryo research licensing * Leadership and governance * Publications and resources * Accountability and reporting 3.
MRFF – 2025 Early to Mid-Career Researchers Grant Opportunity (GO7553) # MRFF – 2025 Early to Mid-Career Researchers Grant Opportunity (GO7553) [](https://www. nhmrc.
gov.au/funding/find-funding/mrff-2025-early-mid-career-researchers-grant-opportunity-go7553) MRFF – Early to Mid-Career Researchers Initiative – 2025 Early to Mid-Career Researchers Grant Opportunity The Medical Research Future Fund (MRFF) – 2025 Early to Mid-Career Researchers Grant Opportunity will support medical research and medical innovation projects that: * **Stream 1** (Incubator): Conduct early stage, small scale research, led by early career researchers, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.
* **Stream 2** (Accelerator): establish a large-scale interdisciplinary research program, led by mid-career researchers, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations. * **Stream 3**(Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early to mid-career researchers into policy and practice.
The anticipated outcome of the research is to improve the health and wellbeing of Australians by: * **Stream 1**(Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations. * **Stream 2** (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.
* **Stream 3** (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. Further information on the MRFF is available from the Department of Health, Disability and Ageing.
## Contact research admin office If you need more information, contact your Research Administration Office in the first instance. If you need help and are unable to satisfy your concern through your Administering Institution (or MRFF Eligible Organisation), contact the Research Help Centre.
Go to the National Health and Medical Research Council home page | Australian Government NHMRC acknowledges the Traditional Custodians of the lands around Australia and pays our respect to their Elders, both past and present. **Your feedback matters** We're always looking for ways to improve our site.
* Connect with the National Health and Medical Research Council on Facebook * Connect with the National Health and Medical Research Council on Twitter * Connect with the National Health and Medical Research Council on LinkedIn * Connect with the National Health and Medical Research Council on Instagram
According to the current listing, eligibility includes: Early to mid-career researchers in health and medical research. Confirm the full requirements in the official notice before applying.
MRFF – 2025 Early to Mid-Career Researchers Grant Opportunity is funded by National Health and Medical Research Council (NHMRC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
Tennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleNICHD's FY2026 funding strategy applies an automatic 14 percent reduction to every new R01 below the peer-review recommended level, eliminates inflationary increases on future-year commitments, and abandons a fixed payline entirely in favor of priority-driven discretion. The structural implications for child health investigators.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read article